img

Global Inactivated Polio Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Inactivated Polio Vaccine Market Insights, Forecast to 2034

Polio vaccines can be classified into two typesthe inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. The oral polio vaccine has the risk of transmission through human waste, causing the regulatory bodies to shift their demand towards IPV. Inactivated polio vaccines (IPV) have now been introduced into all countries’ routine immunization programmes, which are strengthening the fight to eradicate wild poliovirus (WPV).
Global Inactivated Polio Vaccine market is expected to reach to US$ 715.8 million in 2024, with a positive growth of %, compared with US$ 688.5 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Inactivated Polio Vaccine industry is evaluated to reach US$ 926.8 million in 2029. The CAGR will be 4.4% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Inactivated Polio Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Inactivated Polio Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Government
Private Sector

Segment by Application


Pediatrics
Adults

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Inactivated Polio Vaccine plant distribution, commercial date of Inactivated Polio Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Inactivated Polio Vaccine introduction, etc. Inactivated Polio Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Inactivated Polio Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Inactivated Polio Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Inactivated Polio Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Government
1.2.3 Private Sector
1.3 Market by Application
1.3.1 Global Inactivated Polio Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pediatrics
1.3.3 Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Inactivated Polio Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Inactivated Polio Vaccine Revenue by Region
2.2.1 Global Inactivated Polio Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Inactivated Polio Vaccine Revenue by Region (2018-2024)
2.2.3 Global Inactivated Polio Vaccine Revenue by Region (2024-2029)
2.2.4 Global Inactivated Polio Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Inactivated Polio Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Inactivated Polio Vaccine Sales by Region
2.4.1 Global Inactivated Polio Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Inactivated Polio Vaccine Sales by Region (2018-2024)
2.4.3 Global Inactivated Polio Vaccine Sales by Region (2024-2029)
2.4.4 Global Inactivated Polio Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Inactivated Polio Vaccine Sales by Manufacturers
3.1.1 Global Inactivated Polio Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Inactivated Polio Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inactivated Polio Vaccine in 2022
3.2 Global Inactivated Polio Vaccine Revenue by Manufacturers
3.2.1 Global Inactivated Polio Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Inactivated Polio Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Inactivated Polio Vaccine Revenue in 2022
3.3 Global Key Players of Inactivated Polio Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Inactivated Polio Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Inactivated Polio Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Inactivated Polio Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Inactivated Polio Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Inactivated Polio Vaccine Sales by Type
4.1.1 Global Inactivated Polio Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Inactivated Polio Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Inactivated Polio Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Inactivated Polio Vaccine Revenue by Type
4.2.1 Global Inactivated Polio Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Inactivated Polio Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Inactivated Polio Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Inactivated Polio Vaccine Price by Type
4.3.1 Global Inactivated Polio Vaccine Price by Type (2018-2024)
4.3.2 Global Inactivated Polio Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Inactivated Polio Vaccine Sales by Application
5.1.1 Global Inactivated Polio Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Inactivated Polio Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Inactivated Polio Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Inactivated Polio Vaccine Revenue by Application
5.2.1 Global Inactivated Polio Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Inactivated Polio Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Inactivated Polio Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Inactivated Polio Vaccine Price by Application
5.3.1 Global Inactivated Polio Vaccine Price by Application (2018-2024)
5.3.2 Global Inactivated Polio Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Inactivated Polio Vaccine Market Size by Type
6.1.1 US & Canada Inactivated Polio Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Inactivated Polio Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Inactivated Polio Vaccine Market Size by Application
6.2.1 US & Canada Inactivated Polio Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Inactivated Polio Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Inactivated Polio Vaccine Market Size by Country
6.3.1 US & Canada Inactivated Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Inactivated Polio Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Inactivated Polio Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Inactivated Polio Vaccine Market Size by Type
7.1.1 Europe Inactivated Polio Vaccine Sales by Type (2018-2029)
7.1.2 Europe Inactivated Polio Vaccine Revenue by Type (2018-2029)
7.2 Europe Inactivated Polio Vaccine Market Size by Application
7.2.1 Europe Inactivated Polio Vaccine Sales by Application (2018-2029)
7.2.2 Europe Inactivated Polio Vaccine Revenue by Application (2018-2029)
7.3 Europe Inactivated Polio Vaccine Market Size by Country
7.3.1 Europe Inactivated Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Inactivated Polio Vaccine Sales by Country (2018-2029)
7.3.3 Europe Inactivated Polio Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Inactivated Polio Vaccine Market Size
8.1.1 China Inactivated Polio Vaccine Sales (2018-2029)
8.1.2 China Inactivated Polio Vaccine Revenue (2018-2029)
8.2 China Inactivated Polio Vaccine Market Size by Application
8.2.1 China Inactivated Polio Vaccine Sales by Application (2018-2029)
8.2.2 China Inactivated Polio Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Inactivated Polio Vaccine Market Size by Type
9.1.1 Asia Inactivated Polio Vaccine Sales by Type (2018-2029)
9.1.2 Asia Inactivated Polio Vaccine Revenue by Type (2018-2029)
9.2 Asia Inactivated Polio Vaccine Market Size by Application
9.2.1 Asia Inactivated Polio Vaccine Sales by Application (2018-2029)
9.2.2 Asia Inactivated Polio Vaccine Revenue by Application (2018-2029)
9.3 Asia Inactivated Polio Vaccine Sales by Region
9.3.1 Asia Inactivated Polio Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Inactivated Polio Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Inactivated Polio Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Inactivated Polio Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Inactivated Polio Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Inactivated Polio Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Inactivated Polio Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Inactivated Polio Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Inactivated Polio Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sanofi Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 GSK Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Bibcol
11.3.1 Bibcol Company Information
11.3.2 Bibcol Overview
11.3.3 Bibcol Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Bibcol Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bibcol Recent Developments
11.4 Serum Institute
11.4.1 Serum Institute Company Information
11.4.2 Serum Institute Overview
11.4.3 Serum Institute Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Serum Institute Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Serum Institute Recent Developments
11.5 Tiantan Biological
11.5.1 Tiantan Biological Company Information
11.5.2 Tiantan Biological Overview
11.5.3 Tiantan Biological Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Tiantan Biological Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tiantan Biological Recent Developments
11.6 Panacea Biotec
11.6.1 Panacea Biotec Company Information
11.6.2 Panacea Biotec Overview
11.6.3 Panacea Biotec Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Panacea Biotec Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Panacea Biotec Recent Developments
11.7 Bio-Med
11.7.1 Bio-Med Company Information
11.7.2 Bio-Med Overview
11.7.3 Bio-Med Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Bio-Med Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bio-Med Recent Developments
11.8 Halfkin Bio-Pharmaceuticals
11.8.1 Halfkin Bio-Pharmaceuticals Company Information
11.8.2 Halfkin Bio-Pharmaceuticals Overview
11.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Inactivated Polio Vaccine Industry Chain Analysis
12.2 Inactivated Polio Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inactivated Polio Vaccine Production Mode & Process
12.4 Inactivated Polio Vaccine Sales and Marketing
12.4.1 Inactivated Polio Vaccine Sales Channels
12.4.2 Inactivated Polio Vaccine Distributors
12.5 Inactivated Polio Vaccine Customers
13 Market Dynamics
13.1 Inactivated Polio Vaccine Industry Trends
13.2 Inactivated Polio Vaccine Market Drivers
13.3 Inactivated Polio Vaccine Market Challenges
13.4 Inactivated Polio Vaccine Market Restraints
14 Key Findings in The Global Inactivated Polio Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Inactivated Polio Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Government
Table 3. Major Manufacturers of Private Sector
Table 4. Global Inactivated Polio Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Inactivated Polio Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Inactivated Polio Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Inactivated Polio Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Inactivated Polio Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Inactivated Polio Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Inactivated Polio Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Inactivated Polio Vaccine Sales by Region (2018-2024) & (K Dose)
Table 12. Global Inactivated Polio Vaccine Sales by Region (2024-2029) & (K Dose)
Table 13. Global Inactivated Polio Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Inactivated Polio Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Inactivated Polio Vaccine Sales by Manufacturers (2018-2024) & (K Dose)
Table 16. Global Inactivated Polio Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Inactivated Polio Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Inactivated Polio Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Inactivated Polio Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Inactivated Polio Vaccine Price by Manufacturers 2018-2024 (US$/Dose)
Table 21. Global Inactivated Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Inactivated Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Vaccine as of 2022)
Table 23. Global Key Manufacturers of Inactivated Polio Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Inactivated Polio Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Inactivated Polio Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Inactivated Polio Vaccine Sales by Type (2018-2024) & (K Dose)
Table 28. Global Inactivated Polio Vaccine Sales by Type (2024-2029) & (K Dose)
Table 29. Global Inactivated Polio Vaccine Sales Share by Type (2018-2024)
Table 30. Global Inactivated Polio Vaccine Sales Share by Type (2024-2029)
Table 31. Global Inactivated Polio Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Inactivated Polio Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Inactivated Polio Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Inactivated Polio Vaccine Revenue Share by Type (2024-2029)
Table 35. Inactivated Polio Vaccine Price by Type (2018-2024) & (US$/Dose)
Table 36. Global Inactivated Polio Vaccine Price Forecast by Type (2024-2029) & (US$/Dose)
Table 37. Global Inactivated Polio Vaccine Sales by Application (2018-2024) & (K Dose)
Table 38. Global Inactivated Polio Vaccine Sales by Application (2024-2029) & (K Dose)
Table 39. Global Inactivated Polio Vaccine Sales Share by Application (2018-2024)
Table 40. Global Inactivated Polio Vaccine Sales Share by Application (2024-2029)
Table 41. Global Inactivated Polio Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Inactivated Polio Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Inactivated Polio Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Inactivated Polio Vaccine Revenue Share by Application (2024-2029)
Table 45. Inactivated Polio Vaccine Price by Application (2018-2024) & (US$/Dose)
Table 46. Global Inactivated Polio Vaccine Price Forecast by Application (2024-2029) & (US$/Dose)
Table 47. US & Canada Inactivated Polio Vaccine Sales by Type (2018-2024) & (K Dose)
Table 48. US & Canada Inactivated Polio Vaccine Sales by Type (2024-2029) & (K Dose)
Table 49. US & Canada Inactivated Polio Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Inactivated Polio Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Inactivated Polio Vaccine Sales by Application (2018-2024) & (K Dose)
Table 52. US & Canada Inactivated Polio Vaccine Sales by Application (2024-2029) & (K Dose)
Table 53. US & Canada Inactivated Polio Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Inactivated Polio Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Inactivated Polio Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Inactivated Polio Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Inactivated Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Inactivated Polio Vaccine Sales by Country (2018-2024) & (K Dose)
Table 59. US & Canada Inactivated Polio Vaccine Sales by Country (2024-2029) & (K Dose)
Table 60. Europe Inactivated Polio Vaccine Sales by Type (2018-2024) & (K Dose)
Table 61. Europe Inactivated Polio Vaccine Sales by Type (2024-2029) & (K Dose)
Table 62. Europe Inactivated Polio Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Inactivated Polio Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Inactivated Polio Vaccine Sales by Application (2018-2024) & (K Dose)
Table 65. Europe Inactivated Polio Vaccine Sales by Application (2024-2029) & (K Dose)
Table 66. Europe Inactivated Polio Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Inactivated Polio Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Inactivated Polio Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Inactivated Polio Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Inactivated Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Inactivated Polio Vaccine Sales by Country (2018-2024) & (K Dose)
Table 72. Europe Inactivated Polio Vaccine Sales by Country (2024-2029) & (K Dose)
Table 73. China Inactivated Polio Vaccine Sales by Type (2018-2024) & (K Dose)
Table 74. China Inactivated Polio Vaccine Sales by Type (2024-2029) & (K Dose)
Table 75. China Inactivated Polio Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Inactivated Polio Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Inactivated Polio Vaccine Sales by Application (2018-2024) & (K Dose)
Table 78. China Inactivated Polio Vaccine Sales by Application (2024-2029) & (K Dose)
Table 79. China Inactivated Polio Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Inactivated Polio Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Inactivated Polio Vaccine Sales by Type (2018-2024) & (K Dose)
Table 82. Asia Inactivated Polio Vaccine Sales by Type (2024-2029) & (K Dose)
Table 83. Asia Inactivated Polio Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Inactivated Polio Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Inactivated Polio Vaccine Sales by Application (2018-2024) & (K Dose)
Table 86. Asia Inactivated Polio Vaccine Sales by Application (2024-2029) & (K Dose)
Table 87. Asia Inactivated Polio Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Inactivated Polio Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Inactivated Polio Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Inactivated Polio Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Inactivated Polio Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Inactivated Polio Vaccine Sales by Region (2018-2024) & (K Dose)
Table 93. Asia Inactivated Polio Vaccine Sales by Region (2024-2029) & (K Dose)
Table 94. Middle East, Africa and Latin America Inactivated Polio Vaccine Sales by Type (2018-2024) & (K Dose)
Table 95. Middle East, Africa and Latin America Inactivated Polio Vaccine Sales by Type (2024-2029) & (K Dose)
Table 96. Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Inactivated Polio Vaccine Sales by Application (2018-2024) & (K Dose)
Table 99. Middle East, Africa and Latin America Inactivated Polio Vaccine Sales by Application (2024-2029) & (K Dose)
Table 100. Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Inactivated Polio Vaccine Sales by Country (2018-2024) & (K Dose)
Table 106. Middle East, Africa and Latin America Inactivated Polio Vaccine Sales by Country (2024-2029) & (K Dose)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 110. Sanofi Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. GSK Company Information
Table 113. GSK Description and Major Businesses
Table 114. GSK Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 115. GSK Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GSK Recent Developments
Table 117. Bibcol Company Information
Table 118. Bibcol Description and Major Businesses
Table 119. Bibcol Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 120. Bibcol Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bibcol Recent Developments
Table 122. Serum Institute Company Information
Table 123. Serum Institute Description and Major Businesses
Table 124. Serum Institute Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 125. Serum Institute Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Serum Institute Recent Developments
Table 127. Tiantan Biological Company Information
Table 128. Tiantan Biological Description and Major Businesses
Table 129. Tiantan Biological Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 130. Tiantan Biological Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Tiantan Biological Recent Developments
Table 132. Panacea Biotec Company Information
Table 133. Panacea Biotec Description and Major Businesses
Table 134. Panacea Biotec Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 135. Panacea Biotec Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Panacea Biotec Recent Developments
Table 137. Bio-Med Company Information
Table 138. Bio-Med Description and Major Businesses
Table 139. Bio-Med Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 140. Bio-Med Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Bio-Med Recent Developments
Table 142. Halfkin Bio-Pharmaceuticals Company Information
Table 143. Halfkin Bio-Pharmaceuticals Description and Major Businesses
Table 144. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 145. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Halfkin Bio-Pharmaceuticals Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Inactivated Polio Vaccine Distributors List
Table 150. Inactivated Polio Vaccine Customers List
Table 151. Inactivated Polio Vaccine Market Trends
Table 152. Inactivated Polio Vaccine Market Drivers
Table 153. Inactivated Polio Vaccine Market Challenges
Table 154. Inactivated Polio Vaccine Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Inactivated Polio Vaccine Product Picture
Figure 2. Global Inactivated Polio Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Inactivated Polio Vaccine Market Share by Type in 2022 & 2029
Figure 4. Government Product Picture
Figure 5. Private Sector Product Picture
Figure 6. Global Inactivated Polio Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Inactivated Polio Vaccine Market Share by Application in 2022 & 2029
Figure 8. Pediatrics
Figure 9. Adults
Figure 10. Inactivated Polio Vaccine Report Years Considered
Figure 11. Global Inactivated Polio Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Inactivated Polio Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Inactivated Polio Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Inactivated Polio Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Inactivated Polio Vaccine Sales 2018-2029 ((K Dose)
Figure 16. Global Inactivated Polio Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Inactivated Polio Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 18. US & Canada Inactivated Polio Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Inactivated Polio Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 20. Europe Inactivated Polio Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Inactivated Polio Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 22. China Inactivated Polio Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Inactivated Polio Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 24. Asia (excluding China) Inactivated Polio Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Inactivated Polio Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 26. Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Inactivated Polio Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Inactivated Polio Vaccine in the World: Market Share by Inactivated Polio Vaccine Revenue in 2022
Figure 29. Global Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Inactivated Polio Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Inactivated Polio Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Inactivated Polio Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Inactivated Polio Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Inactivated Polio Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Inactivated Polio Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Inactivated Polio Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Inactivated Polio Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Inactivated Polio Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Inactivated Polio Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Inactivated Polio Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Inactivated Polio Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Inactivated Polio Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Inactivated Polio Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Inactivated Polio Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Inactivated Polio Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Inactivated Polio Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Inactivated Polio Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Inactivated Polio Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Inactivated Polio Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Inactivated Polio Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Inactivated Polio Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Inactivated Polio Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Inactivated Polio Vaccine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Inactivated Polio Vaccine Revenue Share by Region (2018-2029)
Figure 62. Asia Inactivated Polio Vaccine Sales Share by Region (2018-2029)
Figure 63. Japan Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. India Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Inactivated Polio Vaccine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Inactivated Polio Vaccine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Inactivated Polio Vaccine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Inactivated Polio Vaccine Sales Share by Country (2018-2029)
Figure 74. Brazil Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Inactivated Polio Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Inactivated Polio Vaccine Value Chain
Figure 80. Inactivated Polio Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries